Programs and Competitions

CQDM launches several competitions each year related to its financing programs. Each targets projects advocating enabling tools or technologies that are designed to accelerate drug discovery and develop safer and more effective treatments for patients. CQDM supports pre-competitive research where technological advances will drive biopharmaceutical R & D productivity.

CQDM’s funding programs aim to provide solutions to the critical needs of the pharmaceutical industry. Therefore, the selection of projects with a high potential impact on biopharmaceutical research regarding its ability to meet the unmet needs will be privileged. CQDM is in search of scientific excellence, creativity and innovative research projects. Each project must generate deliverables, milestones and timelines, be competitive in their field of science and be executed within the time and budget allocated.

Although CQDM’s members share the costs, risks and results of research, the intellectual property resulting from funded research will belong to researchers and their respective institutions. A non-exclusive license option will be given to CQDM’s partners so that the project results will be used for research and development only.

As of today, CQDM has established 10 funding programs, launched 28 competitions and reviewed 770 projects, totaling over $ 767 M in funding requests.


Focus on Brain Program EXPLORE Program Quantum Leap 
Program Specifics
Main Objectives Innovative technologies, tools and platforms that accelerate or facilitate the drug discovery/development process in neurosciences Innovative technologies, tools and platforms that accelerate or facilitate the drug discovery/development process
Scope Large-scale projects that generate applicable results to biopharmaceutical research Early validation of unconventional and highly innovative ideas that could lead to advances in disruptive technologies Funding SMEs and academic researchers to further develop impactful platforms while positioning them advantageously for commercialisation
Targeted Regions
Canada Quebec and Ontario  Canada
Eligibility Academic laboratories and SMEs (Biotechnology companies and Contract Research Organizations). Multinational pharmaceutical companies are not eligible. SMEs   
Competition Specifics
Public/private partnership Encouraged Not required Encouraged
Duration of projects Maximum 3 years Maximum 2 years Depend on the selected research project
Total amount $1,500,000 $300,000 Depend on the selected research project 
Important dates
Call for proposals
September 15th, 2015
Deadline for submission of the letters of intent
December 15th, 2015
Announcement of the selected letters of intent
March 16th, 2016
Deadline to submit full proposals
April 28th, 2016
Final selection announcement
July, 2016
Signature of the research agreement
October, 2016
Funding release and beginning of the projects
November, 2016
Call for proposals
June 30th, 2015
Deadline for submission of the full application
September 4th, 2015
Announcement of the selected full applications
November 2015
Final selection announcement
February 2016
Signature of the research agreement
2 months window
Funding release and beginning of the projects
April 1st, 2016
Open all year long, but applications will be reviewed quarterly. Given the number of projects currently under study, the competition is temporarily closed.  
For more information, click here For more information, click here For more information,  click here

Quebec / France Joint Program Canada / Germany Joint Program Canada / Belgium Joint Program   
Program Specifics
Main Objectives Innovative technologies, tools and platforms that accelerate or facilitate the drug discovery/development process
Scope Large-scale projects that generate applicable results to biopharmaceutical research
Targeted Regions
Quebec/Alsace and Rhône-Alpes Collaboration Canada/Germany Collaboration Canada/Wallonia Collaboration    
Eligibility Academic laboratories and SMEs (Biotechnology companies and Contract Research Organizations). Multinational pharmaceutical companies are not eligible.
Competition Specifics
Public/private partnership Required for Alsace and Rhône-Alpes; encouraged for Quebec Encouraged  
Duration of projects Maximum 3 years Maximum 3 years Minimum 2 years
Total amount $700,000 in Quebec and equivalent in France $1,000,000  
Important dates
Open all year long
Call for proposals
October 1st, 2015
Deadline to submit full proposals
January 15th, 2016
Final selection announcement
May 11th, 2016
Signature of the research agreement
August 15th, 2016
Call for proposals
October 1st, 2015

Deadline for submission of the letters of intent
January 8th, 2016

Deadline to submit full proposals
February 8th, 2016

Final selection announcement
May 23rd, 2016

Signature of the research agreement
August 23rd, 2016

Funding release and beginning of the projects
September 16th, 2016
For more information, click here For more information, click here For more information, click here